For: | Nagashima I, Takada T, Nagawa H, Muto T, Okinaga K. Proposal of a new and simple staging system of colorectal liver metastasis. World J Gastroenterol 2006; 12(43): 6961-6965 [PMID: 17109517 DOI: 10.3748/wjg.v12.i43.6961] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v12/i43/6961.htm |
Number | Citing Articles |
1 |
Christophe Laurent, Jean‐Philippe Adam, Quentin Denost, Denis Smith, Jean Saric, Laurence Chiche. Significance of R1 Resection for Advanced Colorectal Liver Metastases in the Era of Modern Effective Chemotherapy. World Journal of Surgery 2016; 40(5): 1191 doi: 10.1007/s00268-016-3404-6
|
2 |
Fábio Luiz Waechter, Uirá Fernandes Teixeira, Pablo Duarte Rodrigues, Marcio Boff, Rinaldo Danesi, Mauro Monteiro Correia. Colorectal Cancer Liver Metastases. 2020; : 355 doi: 10.1007/978-3-030-25486-5_27
|
3 |
Giacomo Puppa, Angelica Sonzogni, Romano Colombari, Giuseppe Pelosi. TNM Staging System of Colorectal Carcinoma: A Critical Appraisal of Challenging Issues. Archives of Pathology & Laboratory Medicine 2010; 134(6): 837 doi: 10.5858/134.6.837
|
4 |
X-Y Wang, R Zhang, Z Wang, Y Geng, J Lin, K Ma, J-L Zuo, L Lu, J-B Zhang, W-W Zhu, J-H Chen. Meta-analysis of the association between primary tumour location and prognosis after surgical resection of colorectal liver metastases. British Journal of Surgery 2019; 106(13): 1747 doi: 10.1002/bjs.11289
|
5 |
Christina Villard, Ahmed Abdelrafee, Miriam Habib, Nelson Ndegwa, Carl Jorns, Ernesto Sparrelid, Marc-Antoine Allard, René Adam. Prediction of survival in patients with colorectal liver metastases- development and validation of a prognostic score model. European Journal of Surgical Oncology 2022; 48(12): 2432 doi: 10.1016/j.ejso.2022.06.021
|
6 |
Kathleen De Greef, Christian Rolfo, Antonio Russo, Thiery Chapelle, Giuseppe Bronte, Francesco Passiglia, Andreia Coelho, Konstantinos Papadimitriou, Marc Peeters. Multisciplinary management of patients with liver metastasis from colorectal cancer. World Journal of Gastroenterology 2016; 22(32): 7215-7225 doi: 10.3748/wjg.v22.i32.7215
|
7 |
David B. Donner, Dan T. Ruan, Kan Toriguchi, Emily K. Bergsland, Eric K. Nakakura, Meng Hsun Lin, Ricardo J. Antonia, Robert S. Warren. Mitogen Inducible Gene-6 Is a Prognostic Marker for Patients with Colorectal Liver Metastases. Translational Oncology 2019; 12(3): 550 doi: 10.1016/j.tranon.2018.12.007
|
8 |
András Petri, József Hőhn, Ádám Balogh, Kornél Kovách, László Andrási, György Lázár. Colorectalis rák májáttéteinek sebészi kezelése szinkron májreszekcióval. Magyar Onkológia 2010; 54(2): 125 doi: 10.1556/MOnkol.54.2010.2.6
|
9 |
Alexander Stein, Joern Rüssel, Stefan Peinert, Dirk Arnold. The role of peri-operative treatment in resectable liver metastases of colorectal cancer. Therapeutic Advances in Medical Oncology 2010; 2(6): 389 doi: 10.1177/1758834010375095
|
10 |
Silvia Inés Guerrero Macías, Juan Javier Acevedo, Helena Facundo Navia, Oscar Alexander Guevara Cruz. Mutación del gen KRAS en pacientes llevados a resecciones hepáticas por cáncer colorrectal. ¿Hay ventaja en las resecciones anatómicas?. Revista colombiana de Gastroenterología 2023; 38(1): 19 doi: 10.22516/25007440.929
|
11 |
Dirk Arnold, Alexander Stein. Adjuvant Therapy After Liver Resection for Colorectal Cancer Metastasis: What is the Evidence?. Current Colorectal Cancer Reports 2011; 7(2): 180 doi: 10.1007/s11888-011-0096-z
|
12 |
Alexander Stein, Hans-Joachim Schmoll. Multidisciplinary Management of Rectal Cancer. 2012; : 205 doi: 10.1007/978-3-642-25005-7_21
|
13 |
D J Watkins, I Chau, D Cunningham, S S Mudan, N Karanjia, G Brown, S Ashley, A R Norman, A Gillbanks. Defining patient outcomes in stage IV colorectal cancer: a prospective study with baseline stratification according to disease resectability status. British Journal of Cancer 2010; 102(2): 255 doi: 10.1038/sj.bjc.6605508
|
14 |
Aurélien Dupré, Adeeb Rehman, Robert P. Jones, Alex Parker, Rafael Diaz‐Nieto, Stephen W. Fenwick, Graeme J. Poston, Hassan Z. Malik. Validation of clinical prognostic scores for patients treated with curative‐intent for recurrent colorectal liver metastases. Journal of Surgical Oncology 2018; 117(6): 1330 doi: 10.1002/jso.24959
|
15 |
A. Dupré, S. Berhane, A.W.H. Chan, M. Rivoire, C.C.N. Chong, P.B.S. Lai, A. Cucchetti, Graeme J. Poston, H.Z. Malik, P.J. Johnson. Multicentre validation of a clinical prognostic score integrating the systemic inflammatory response to the host for patients treated with curative-intent for colorectal liver metastases: The Liverpool score. European Journal of Surgical Oncology 2019; 45(6): 999 doi: 10.1016/j.ejso.2019.02.022
|
16 |
Jan P. Jonas, Hubert Hackl, David Pereyra, Jonas Santol, Gregor Ortmayr, Benedikt Rumpf, Sina Najarnia, Dominic Schauer, Christine Brostjan, Thomas Gruenberger, Patrick Starlinger. Circulating metabolites as a concept beyond tumor biology determining disease recurrence after resection of colorectal liver metastasis. HPB 2022; 24(1): 116 doi: 10.1016/j.hpb.2021.06.415
|
17 |
Alexander Stein, Gabriel Glockzin, Andreas Wienke, Dirk Arnold, Thomas Edelmann, Bert Hildebrandt, Stephan Hollerbach, Gerald Illerhaus, Alfred Königsrainer, Michael Richter, Hans J Schlitt, Hans-Joachim Schmoll. Treatment with bevacizumab and FOLFOXIRI in patients with advanced colorectal cancer: presentation of two novel trials (CHARTA and PERIMAX) and review of the literature. BMC Cancer 2012; 12(1) doi: 10.1186/1471-2407-12-356
|
18 |
Katharina Joechle, Iakovos Amygdalos, Felix Schmidt, Jan Bednarsch, Alexandros Chrysos, Franziska A. Meister, Zoltan Czigany, Daniel Heise, Marie-Luise Berres, Philipp Bruners, Tom F. Ulmer, Ulf P. Neumann, Sven A. Lang. Value of prognostic scoring systems in the era of multimodal therapy for recurrent colorectal liver metastases. HPB 2023; 25(11): 1354 doi: 10.1016/j.hpb.2023.06.016
|
19 |
Ninos Ayez, Zarina S. Lalmahomed, Alexander M. M. Eggermont, Jan N. M. Ijzermans, Jeroen de Jonge, Kees van Montfort, Cornelis Verhoef. Outcome of Microscopic Incomplete Resection (R1) of Colorectal Liver Metastases in the Era of Neoadjuvant Chemotherapy. Annals of Surgical Oncology 2012; 19(5): 1618 doi: 10.1245/s10434-011-2114-4
|
20 |
Yan‐Long Liu, Hai‐tao Xu, Shi‐Xiong Jiang, Yan‐Mei Yang, Bin‐Bin Cui. Prognostic significance of lymph node status in patients with metastatic colorectal carcinoma treated with lymphadenectomy. Journal of Surgical Oncology 2014; 109(3): 234 doi: 10.1002/jso.23479
|
21 |
Giacomo Puppa. TNM staging system of colorectal carcinoma: surgical pathology of the seventh edition. Diagnostic Histopathology 2011; 17(6): 243 doi: 10.1016/j.mpdhp.2011.03.006
|
22 |
Francesco Passiglia, Giuseppe Bronte, Viviana Bazan, Antonio Galvano, Bruno Vincenzi, Antonio Russo. Can KRAS and BRAF mutations limit the benefit of liver resection in metastatic colorectal cancer patients? A systematic review and meta-analysis. Critical Reviews in Oncology/Hematology 2016; 99: 150 doi: 10.1016/j.critrevonc.2015.12.015
|